160 related articles for article (PubMed ID: 31116803)
1. The HPV-18 E7 CKII phospho acceptor site is required for maintaining the transformed phenotype of cervical tumour-derived cells.
Basukala O; Mittal S; Massimi P; Bestagno M; Banks L
PLoS Pathog; 2019 May; 15(5):e1007769. PubMed ID: 31116803
[TBL] [Abstract][Full Text] [Related]
2. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
Ryzhakova OS; Solov'eva NI
Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus.
Yun HY; Kim MW; Lee HS; Kim W; Shin JH; Kim H; Shin HC; Park H; Oh BH; Kim WK; Bae KH; Lee SC; Lee EW; Ku B; Kim SJ
PLoS Biol; 2019 Jul; 17(7):e3000367. PubMed ID: 31323018
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex.
Tugizov S; Berline J; Herrera R; Penaranda ME; Nakagawa M; Palefsky J
J Virol; 2005 Jan; 79(2):1099-112. PubMed ID: 15613338
[TBL] [Abstract][Full Text] [Related]
5. Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.
Chien WM; Parker JN; Schmidt-Grimminger DC; Broker TR; Chow LT
Cell Growth Differ; 2000 Aug; 11(8):425-35. PubMed ID: 10965847
[TBL] [Abstract][Full Text] [Related]
6. Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression.
Dizanzo MP; Bugnon Valdano M; Basukala O; Banks L; Gardiol D
BMC Cancer; 2022 Sep; 22(1):1015. PubMed ID: 36153517
[TBL] [Abstract][Full Text] [Related]
7. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
8. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
9. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300.
Bernat A; Avvakumov N; Mymryk JS; Banks L
Oncogene; 2003 Sep; 22(39):7871-81. PubMed ID: 12970734
[TBL] [Abstract][Full Text] [Related]
10. HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.
Massimi P; Pim D; Storey A; Banks L
Oncogene; 1996 Jun; 12(11):2325-30. PubMed ID: 8649772
[TBL] [Abstract][Full Text] [Related]
11. HPV-16 E7 Interacts with the Endocytic Machinery via the AP2 Adaptor μ2 Subunit.
Basukala O; Trejo-Cerro O; Myers MP; Pim D; Massimi P; Thomas M; Guarnaccia C; Owen D; Banks L
mBio; 2022 Dec; 13(6):e0230222. PubMed ID: 36255238
[TBL] [Abstract][Full Text] [Related]
12. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.
Barbosa MS; Edmonds C; Fisher C; Schiller JT; Lowy DR; Vousden KH
EMBO J; 1990 Jan; 9(1):153-60. PubMed ID: 2153075
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.
Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K
J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271
[TBL] [Abstract][Full Text] [Related]
14. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor.
Maldonado E; Cabrejos ME; Banks L; Allende JE
J Cell Biochem; 2002; 85(4):663-9. PubMed ID: 11968006
[TBL] [Abstract][Full Text] [Related]
16. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
17. Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle.
Massimi P; Banks L
Virology; 2000 Oct; 276(2):388-94. PubMed ID: 11040129
[TBL] [Abstract][Full Text] [Related]
18. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
19. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
[TBL] [Abstract][Full Text] [Related]
20. The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II.
Firzlaff JM; Galloway DA; Eisenman RN; Lüscher B
New Biol; 1989 Oct; 1(1):44-53. PubMed ID: 2562189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
